Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG 1 1For a complete list of the members of the Children’s Oncology Group Soft Tissue Sarcoma Committee (formerly Intergroup Rhabdomyosarcoma Group) representing the Children’s Oncology Group and the Quality Assurance Review Center, see the Appendix.

This publication has 33 references indexed in Scilit:

• Hyperfractionated radiation in children with rhabdomyosarcoma—Results of an intergroup rhabdomyosarcoma pilot study
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
  Radiotherapy and Oncology, 1992
• Status of the experience of the EORTC cooperative group of radiotherapy with hyperfractionated and accelerated radiotherapy regimes
  Seminars in Radiation Oncology, 1992
• The linear-quadratic formula and progress in fractionated radiotherapy
  The British Journal of Radiology, 1989
• Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rhabdomyosarcoma (RMS)
  International Journal of Radiation Oncology*Biology*Physics, 1988
• Late effects of therapy in orbital rhabdomyosarcoma in children. A report from the intergroup rhabdomyosarcoma study
  Cancer, 1986
• Twice-a-day radiation therapy for supraglottic carcinoma
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Improved local control for advanced oropharyngeal carcinoma following twice daily radiation therapy
  American Journal of Clinical Oncology, 1985
• Acute and late effects on normal tissues following combined chemo- and radiotherapy for childhood rhabdomyosarcoma and Ewing's sarcoma
  Cancer, 1976
• Rhabdomyosarcoma of head and neck in children
  Cancer, 1973